These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 520399
1. Food-induced reduction in bioavailability of atenolol. Melander A, Stenberg P, Liedholm H, Scherstén B, Wåhlin-Boll E. Eur J Clin Pharmacol; 1979 Nov; 16(5):327-30. PubMed ID: 520399 [Abstract] [Full Text] [Related]
7. The effect of antacid, metoclopramide, and propantheline on the bioavailability of metoprolol and atenolol. Regårdh CG, Lundborg P, Persson BA. Biopharm Drug Dispos; 1981 Nov; 2(1):79-87. PubMed ID: 7236872 [Abstract] [Full Text] [Related]
8. Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol. Hallengren B, Nilsson OR, Karlberg BE, Melander A, Tegler L, Wåhlin-Boll E. Eur J Clin Pharmacol; 1982 Nov; 21(5):379-84. PubMed ID: 7075643 [Abstract] [Full Text] [Related]
9. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol. Gangji D, Juvent M, Niset G, Wathieu M, Degreve M, Bellens R, Poortmans J, Degre S, Fitzsimons TJ, Herchuelz A. Br J Clin Pharmacol; 1984 Nov; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337 [Abstract] [Full Text] [Related]
11. Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assay. Wellstein A, Palm D, Belz GG, Leopold G, Bühring KU, Pabst J. J Cardiovasc Pharmacol; 1986 Nov; 8 Suppl 11():S41-5. PubMed ID: 2439797 [Abstract] [Full Text] [Related]
12. Enhancement of the bioavailability of propranolol and metoprolol by food. Melander A, Danielson K, Scherstén B, Wåhlin E. Clin Pharmacol Ther; 1977 Jul; 22(1):108-12. PubMed ID: 872491 [Abstract] [Full Text] [Related]
14. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Brown HC, Carruthers SG, Johnston GD, Kelly JG, McAinsh J, McDevitt DG, Shanks RG. Clin Pharmacol Ther; 1976 Nov; 20(5):524-34. PubMed ID: 10125 [Abstract] [Full Text] [Related]
15. Pharmacokinetics, pharmacology of atenolol and effect of renal disease. Wan SH, Koda RT, Maronde RF. Br J Clin Pharmacol; 1979 Jun; 7(6):569-74. PubMed ID: 465278 [Abstract] [Full Text] [Related]
16. Interaction between the beta-adrenoceptor blockers metoprolol and atenolol with amitriptyline and their effects on oxidative liver metabolism. Kirch W, Spahn H, Kitteringham NR, Hutt HJ, Mutschler E, Ohnhaus EE. Br J Clin Pharmacol; 1984 Jun; 17 Suppl 1(Suppl 1):65S-68S. PubMed ID: 6743476 [Abstract] [Full Text] [Related]
17. Transplacental passage of atenolol in man. Melander A, Niklasson B, Ingemarsson I, Liedholm H, Scherstén B, Sjöberg NO. Eur J Clin Pharmacol; 1978 Nov 16; 14(2):93-4. PubMed ID: 720380 [Abstract] [Full Text] [Related]
18. Lack of a pharmacokinetic interaction between nifedipine and the beta-adrenoceptor blockers metoprolol and atenolol. Kendall MJ, Jack DB, Laugher SJ, Lobo J, Rolf Smith S. Br J Clin Pharmacol; 1984 Sep 16; 18(3):331-5. PubMed ID: 6487472 [Abstract] [Full Text] [Related]
19. Bioavailability in man of atenolol and chlorthalidone from a combination formulation. McAinsh J, Bastain W, Young J, Harry JD. Biopharm Drug Dispos; 1981 Sep 16; 2(2):147-56. PubMed ID: 7248478 [Abstract] [Full Text] [Related]